{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:19:45Z","timestamp":1791980385953,"version":"4.4.0"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The Constitutive Androstane Receptor (CAR) (NR1I3), a pivotal member of the xenosensor family, plays a key role in the hepatic detoxification of xenobiotic and endobiotic chemicals through the induction of the expression of drug-metabolizing enzymes and transporters. CAR\u2019s involvement extends beyond detoxification, influencing gluconeogenesis, lipogenesis, bile acid regulation, and cellular processes such as proliferation, tissue regeneration, and carcinogenesis. This review explores CAR regulation by various factors, highlighting its role in mediating metabolic changes induced by environmental contaminants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search was conducted to identify all articles on the PubMed website in which the CAR-contaminant and CAR-hepatic steatosis relationship is analyzed in both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Numerous contaminants, such as perfluorooctanoic acid (PFOA), Zearalenone mycotoxin, PCB, triazole fungicide propiconazole can activate hepatic nuclear receptors contributing to the development of steatosis through increased <jats:italic>de novo<\/jats:italic> lipogenesis, decreased fatty acid oxidation, increased hepatic lipid uptake, and decreased gluconeogenesis. Indirect CAR activation pathways, particularly involving PFOA, are discussed in the context of PPAR\u03b1-independent mechanisms leading to hepatotoxicity, including hepatocellular hypertrophy and necrosis, and their implications in nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD). The prevalence of NAFLD, a significant component of metabolic syndrome, underscores the importance of understanding CAR\u2019s role in its pathogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Experimental and epidemiological data suggest that endocrine disruptors, especially pesticides, play a significant role in NAFLD\u2019s development and progression via CAR-regulated pathways. This review advocates for the inclusion of modern toxicological risk assessment tools, such as New Approach Methodologies (NAMs), Adverse Outcome Pathways (AOPs), and Integrated Approaches to Testing and Assessment (IATA), to elucidate CAR-mediated effects and enhance regulatory frameworks.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1472563","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:46:05Z","timestamp":1743767165000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Constitutive androstane receptor, liver pathophysiology and chemical contaminants: current evidence and perspectives"],"prefix":"10.3389","volume":"16","author":[{"given":"Francesca","family":"De Battistis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra Buha","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Saso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/IJTR.S19985","article-title":"The aryl hydrocarbon receptor: a review of its role in the physiology and pathology of the integument and its relationship to the tryptophan metabolism","volume":"8","author":"Noakes","year":"2015","journal-title":"Int J Tryptophan Res"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2018.05.049","article-title":"Atrazine-xenobiotic nuclear receptor interactions induce cardiac inflammation and endoplasmic reticulum stress in quail (Coturnix coturnix)","volume":"206","author":"Li","year":"2018","journal-title":"Chemosphere."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2016.02.009","article-title":"PXR- and CAR-mediated herbal effect on human diseases","volume":"1859","author":"Xu","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1464655","article-title":"Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential","author":"Xu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212482200","article-title":"A novel distal enhancer module regulated by pregnane x Receptor\/Constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2006.12.006","article-title":"CAR and PXR: the xenobiotic-sensing receptors","volume":"72","author":"Timsit","year":"2007","journal-title":"Steroids"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.081042","article-title":"The roles of xenobiotic receptors: beyond chemical disposition","volume":"46","author":"Mackowiak","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/mp700103m","article-title":"Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response","volume":"5","author":"Moreau","year":"2008","journal-title":"Mol Pharm"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-019-02445-2","article-title":"Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines","volume":"93","author":"Knebel","year":"2019","journal-title":"Arch Toxicol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/aps.2014.102","article-title":"Deciphering the roles of the constitutive androstane receptor in energy metabolism","volume":"36","author":"Yan","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.taap.2016.05.006","article-title":"Activation of the constitutive androstane receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way","volume":"303","author":"Marmugi","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2014-0006","article-title":"Nuclear hormone receptors PXR and CAR and metabolic diseases","volume":"19","author":"Mo","year":"2014","journal-title":"Horm. Mol Biol Clin Investig"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.685237","article-title":"Role of CAR and PXR in xenobiotic sensing and metabolism","volume":"8","author":"Wang","year":"2012","journal-title":"Expert. Opin Drug Metab Toxicol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.11.011","article-title":"Targeting xenobiotic receptors PXR and CAR in human diseases","volume":"20","author":"Banerjee","year":"2015","journal-title":"Drug Discovery Today"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod Toxicol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ Toxicol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14040279","article-title":"Providing biological plausibility for exposure-health relationships for the mycotoxins deoxynivalenol (DON) and fumonisin B1 (FB1) in humans using the AOP framework","volume":"14","author":"van den Brand","year":"2022","journal-title":"Toxins (Basel)."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154464","article-title":"Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework","volume":"11","author":"Clerbaux","year":"2022","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-017-2045-3","article-title":"Adverse outcome pathways: opportunities, limitations and open questions","volume":"91","author":"Leist","year":"2017","journal-title":"Arch Toxicol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2015.1089471","article-title":"The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways","volume":"46","author":"Mellor","year":"2016","journal-title":"Crit Rev Toxicol"},{"key":"B23","unstructured":""},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0014-5793(03)00720-8","article-title":"Identification of the nuclear receptor CAR: HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital","volume":"548","author":"Yoshinari","year":"2003","journal-title":"FEBS Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-013-0013-0","article-title":"Signaling control of the constitutive androstane receptor (CAR)","volume":"5","author":"Yang","year":"2014","journal-title":"Protein Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.134642","article-title":"Use of Tox21 screening data to profile PFAS bioactivities on nuclear receptors, cellular stress pathways, and cytochrome p450 enzymes","author":"Ooka","year":"2024","journal-title":"J Hazard Mater"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31521","article-title":"Yes-associated protein is crucial for constitutive androstane receptor-driven hepatocyte proliferation but not for induction of drug metabolism genes in mice","volume":"73","author":"Bhushan","year":"2021","journal-title":"Hepatology."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.754010","article-title":"Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond","volume":"9","author":"Chai","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.10.5652","article-title":"The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene","volume":"18","author":"Honkakoski","year":"1998","journal-title":"Mol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.9.6318","article-title":"Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene","volume":"19","author":"Kawamoto","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.019505","article-title":"Serine 202 regulates the nuclear translocation of constitutive active\/androstane receptor","volume":"69","author":"Hosseinpour","year":"2006","journal-title":"Mol Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.06.129","article-title":"Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR- interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver","volume":"347","author":"Guo","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.18.7931-7940.2004","article-title":"Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes","volume":"24","author":"Kodama","year":"2004","journal-title":"Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M510713200","article-title":"Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid\/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha","volume":"281","author":"Miao","year":"2006","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/me.2015-1145","article-title":"CAR suppresses hepatic gluconeogenesis by facilitating the ubiquitination and degradation of PGC1alpha","volume":"29","author":"Gao","year":"2015","journal-title":"Mol Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30131","article-title":"Pregnane X receptor regulates liver size and liver cell fate by yes-associated protein activation in mice","volume":"69","author":"Jiang","year":"2019","journal-title":"Hepatology."},{"key":"B37","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2741\/3893","article-title":"Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease","volume":"16","author":"Kakizaki","year":"2011","journal-title":"Front Biosci (Landmark Ed)."},{"key":"B38","article-title":"Direct activation of constitutive androstane receptor by phthalates","volume-title":"Proceedings of the 2016 international conference on biological engineering and pharmacy (BEP 2016)","author":"Li","year":"2016"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.2174\/138920008785821666","article-title":"New insights on the xenobiotic-sensing nuclear receptors in liver diseases -CAR and RXR","volume":"9","author":"Kakizaki","year":"2008","journal-title":"Curr Drug Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00267","article-title":"Role of nuclear receptors PXR and CAR in xenobiotic-induced hepatocyte proliferation and chemical carcinogenesis","volume":"42","author":"Yoshinari","year":"2019","journal-title":"Biol Pharm Bull"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2012.07.003","article-title":"Targeting xenobiotic receptors PXR and CAR for metabolic diseases","volume":"33","author":"Gao","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M800226-JLR200","article-title":"The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress","volume":"50","author":"Maglich","year":"2009","journal-title":"J Lipid Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.120.000103","article-title":"Antiepileptic drug-activated constitutive androstane receptor inhibits peroxisome proliferator-activated receptor a and peroxisome proliferator-activated receptor c coactivator 1a- dependent gene expression to increase blood triglyceride levels","volume":"98","author":"Shizu","year":"2020","journal-title":"Mol Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s41467-019-09152-7","article-title":"Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism","volume":"10","author":"Bertolio","year":"2019","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R000017200","article-title":"Osborne TF sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action","volume":"275","year":"2000","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(00)00140-2","article-title":"Regulation of gene expression by SREBP and SCAP","volume":"1529","author":"Edwards","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/biom6030029","article-title":"Role of transcription factors in steatohepatitis and hypertension after ethanol: the epicenter of metabolism","volume":"6","author":"Ansari","year":"2016","journal-title":"Biomolecules."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-1435","article-title":"Hepatic expression of thyroid hormone-responsive spot 14 protein is regulated by constitutive androstane receptor (NR1I3)","volume":"151","author":"Breuker","year":"2010","journal-title":"Endocrinology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/toxsci\/kfac032","article-title":"Impact of neonatal activation of nuclear receptor CAR (Nr1i3) on cyp2 gene expression in adult mouse liver","volume":"187","author":"Shin","year":"2022","journal-title":"Toxicol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174355","article-title":"Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9\/10\/13-null mice","volume":"12","author":"Kumar","year":"2017","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100930","article-title":"Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism","volume":"6","author":"Huillet","year":"2023","journal-title":"JHEP Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfad129","article-title":"Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation","volume":"198","author":"Shizu","year":"2024","journal-title":"Toxicol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102306","article-title":"Metabolism-disrupting chemicals and the constitutive androstane receptor CAR","volume":"9","author":"K\u00fcblbeck","year":"2020","journal-title":"Cells."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2903\/j.efsa.2010.1892","article-title":"Conclusion on the peer review of the pesticide risk assessment of the active substance bromuconazole","volume":"8","year":"2010","journal-title":"EFSA J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/15287390701380914","article-title":"In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessment","volume":"70","author":"Mazur","year":"2007","journal-title":"J Toxicol Environ Health"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2017.1333555","article-title":"Bromuconazole-induced hepatotoxicity is accompanied by upregulation of PXR\/CYP3A1 and downregulation of CAR\/CYP2B1 gene expression","author":"Abdelhadya, Doaa.","year":"2017","journal-title":"Toxicol Mech Methods"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051192","article-title":"The connection of azole fungicides with xeno-sensing nuclear receptors, drug metabolism and hepatotoxicity","volume":"9","author":"Marx-Stoelting","year":"2020","journal-title":"Cells 11;"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000483","article-title":"Clinical relevance of the constitutive androstane receptor","volume":"50","author":"Stern","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2021.116940","article-title":"Fungicide bromuconazole has the potential to induce hepatotoxicity at the physiological, metabolomic and transcriptomic levels in rats","volume":"280","author":"Wu","year":"2021","journal-title":"Environ pollut"},{"key":"B61","doi-asserted-by":"publisher","first-page":"067007","DOI":"10.1289\/EHP2877","article-title":"Metabolic effects of a chronic dietary exposure to a low-dose pesticide cocktail in mice: sexual dimorphism and role of the constitutive androstane receptor","volume":"126","author":"Lukowicz","year":"2018","journal-title":"Environ Health Perspect"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3445","article-title":"Toxaphene-induced mouse liver tumorigenesis is mediated by the constitutive androstane receptor","volume":"37","author":"Wang","year":"2017","journal-title":"J Appl Toxicol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02781-8","article-title":"Constitutive androstane receptor (CAR) mediates dieldrin-induced liver tumorigenesis in mouse","volume":"94","author":"Wang","year":"2020","journal-title":"Arch Toxicol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.135061","article-title":"Estimated daily intake of per- and polyfluoroalkyl substances related to different particle size fractions of house dust","volume":"303","author":"Gustafsson","year":"2022","journal-title":"Chemosphere."},{"key":"B65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bcp.2015.08.087","article-title":"Wang h genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells","volume":"98","author":"Li","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2131\/jts.28.49","article-title":"Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals","volume":"28","author":"Kudo","year":"2003","journal-title":"J Toxicol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.10334","article-title":"Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth","volume":"115","author":"Apelberg","year":"2007","journal-title":"Environ Health Perspect"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2010.03.004","article-title":"The occurrence of perfluorinated alkyl compounds in human milk from different regions of China","volume":"36","author":"Liu","year":"2010","journal-title":"Environ Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2010.04.016","article-title":"Infant exposure of perfluorinated compounds: levels in breast milk and commercial baby food","volume":"36","author":"Llorca","year":"2010","journal-title":"Environ Int"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ Toxicol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.5937\/arhfarm71-34197","article-title":"Endocrine disruption by PFAS: A major concern associated with legacy and replacement substances","volume":"71","author":"Panieri","year":"2021","journal-title":"Arh Farm (Belgr)."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/toxics10020044","article-title":"PFAS molecules: A major concern for the human health and the environment","volume":"10","author":"Panieri","year":"2022","journal-title":"Toxics."},{"key":"B73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2903\/j.efsa.2015.3978","article-title":"Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs","volume":"13","year":"2015","journal-title":"EFSA J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/TOXSCI\/KFN025","article-title":"Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR","volume":"103","author":"Rosen","year":"2008","journal-title":"Toxicol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2903\/j.efsa.2019.5838","article-title":"Scientific Opinion on the update of the risk assessment of di-butylphthalate (DBP), butyl-benzyl-phthalate (BBP), bis(2-ethylhexyl)phthalate (DEHP), di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP) for use in food contact materials","volume":"17","author":"Silano","year":"2019","journal-title":"EFSA J"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-016-1888-3","article-title":"Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid","volume":"91","author":"Abe","year":"2017","journal-title":"Arch Toxicol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/J.TOX.2021.152789","article-title":"Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure","volume":"457","author":"Houck","year":"2021","journal-title":"Toxicology."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2141","article-title":"Metamizole is a moderate cytochrome P450 inducer via the constitutive androstane receptor and a weak inhibitor of CYP1A2","volume":"109","author":"Bachmann","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f706e0","article-title":"Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes","volume":"18","author":"Roth","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfae057","article-title":"Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression","volume":"200","author":"Sonkar","year":"2024","journal-title":"Toxicol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153577","article-title":"Effects of perfluorooctanoic acid (PFOA) on gene expression profiles via nuclear receptors in HepaRG cells: Comparative study with in vitro transactivation assays","volume":"494","author":"Murase","year":"2023","journal-title":"Toxicology."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043953","article-title":"PPAR\u03b1 induces the expression of CAR that works as a negative regulator of PPAR\u03b1 functions in mouse livers","volume":"24","author":"Shizu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9070157","article-title":"Comprehensive insight from phthalates occurrence: from health outcomes to emerging analytical approaches","volume":"9","author":"Lu\u00eds","year":"2021","journal-title":"Toxics"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9050603","article-title":"Phthalates and their impacts on human health","volume":"9","author":"Wang","year":"2021","journal-title":"Healthcare"},{"key":"B85","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mrrev.2012.03.001","article-title":"DEHP: Genotoxicity and potential carcinogenic mechanisms\u2014A review","volume":"751","author":"Caldwell","year":"2012","journal-title":"Mutat Research\/Reviews Mutat Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.02.023","article-title":"Di-(2-ethylhexyl)-phthalate (DEHP) activates the constitutive androstane receptor (CAR): a novel signalling pathway sensitive to phthalates","volume":"77","author":"Eveillard","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2010.03.002","article-title":"In utero exposure to di-(2-ethylhexyl) phthalate affects liver morphology and metabolism in post-natal CD-1 mice","volume":"29","author":"Maranghi","year":"2010","journal-title":"Reprod Toxicol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.6b00186","article-title":"Activation of the constitutive androstane receptor by monophthalates","volume":"29","author":"Laurenzana","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"B89","article-title":"Direct activation of constitutive androstane receptor by phthalates (2016)","author":"Li","year":"2016"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2007.07.010","article-title":"Human exposure to bisphenol A (BPA)","volume":"24","author":"Vandenberg","year":"2007","journal-title":"Reprod Toxicology."},{"key":"B91","first-page":"doi:10.2903\/j.efsa.2015.4302","article-title":"Conclusion on the peer review of the pesticide risk assessment of the active substance glyphosate","volume":"13","year":"2015","journal-title":"EFSA J"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192315918","article-title":"Exposure to bisphenol A substitutes, bisphenol S and bisphenol F, and its association with developing obesity and diabetes mellitus: A narrative review","volume":"19","author":"Alharbi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/62.2.221","article-title":"Metabolic activation of bisphenol A by rat liver S9 fraction","volume":"62","author":"Yoshihara","year":"2001","journal-title":"Toxicol Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.taap.2003.08.001","article-title":"Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor","volume":"193","author":"Mikamo","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114610","article-title":"Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors","volume":"377","author":"Liu","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107251","article-title":"The association between endocrine disrupting chemicals and nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"205","author":"Pan","year":"2024","journal-title":"Pharmacol Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108690","article-title":"Multi-omics approach characterizes the role of Bisphenol F in disrupting hepatic lipid metabolism","volume":"187","author":"Fan","year":"2024","journal-title":"Environ Int"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2023.2288533","article-title":"Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3","volume":"1","author":"Zhang","year":"2023","journal-title":"Arch Physiol Biochem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2903\/j.efsa.2020.6223","article-title":"Scientific Opinion on the risk to human health related to the presence of perfluoroalkyl substances in food","volume":"18","author":"Schrenk","year":"2020","journal-title":"EFSA J"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi288","article-title":"Differential expression of CYP1A, 2B, and 3A genes in the F344 rat following exposure to a polybrominated diphenyl ether mixture or individual components","volume":"88","author":"Sanders","year":"2005","journal-title":"Toxicological Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tox.2009.07.009","article-title":"Technical pentabromodiphenyl ether and hexabromocyclododecane as activators of the pregnane-X-receptor (PXR)","volume":"264","author":"Fery","year":"2009","journal-title":"Toxicology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/toxsci\/kfn230","article-title":"Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups","volume":"107","author":"Szabo","year":"2009","journal-title":"Toxicological Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/toxsci\/kfm025","article-title":"The flame retardants, polybrominated diphenyl ethers, are pregnane X receptor activators","volume":"97","author":"Pacyniak","year":"2007","journal-title":"Toxicological Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2008.05.025","article-title":"A technical mixture of 2,2\u2032,4,4\u2032-tetrabromo diphenyl ether (BDE47) and brominated furans triggers aryl hydrocarbon receptor (AhR) mediated gene expression and toxicity","volume":"73","author":"Wahl","year":"2008","journal-title":"Chemosphere"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.164714","article-title":"Toxicity and risk priority ranking of polybrominated diphenyl ethers (PBDEs): A relative receptor-bound concentration approach","author":"Liu","year":"2023","journal-title":"Sci Total Environ"},{"key":"B106","unstructured":""},{"key":"B107","unstructured":""},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0438010100","article-title":"Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor","volume":"100","author":"Xie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/07853890310008224","article-title":"Drug-activated nuclear receptors CAR and PXR","volume":"35","author":"Honkakoski","year":"2003","journal-title":"Ann Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166101","article-title":"The xenobiotic receptors PXR and CAR in liver physiology, an update","volume":"1867","author":"Cai","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.03.003","article-title":"PXR and CAR in energy metabolism","volume":"20","author":"Wada","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1042\/bj3500389","article-title":"Insulin effects on sterol regulatory-elementbinding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes","volume":"350","author":"Azzout-Marniche","year":"2000","journal-title":"Biochem J"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12737","article-title":"Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expressionof glucokinase and lipogenesis- related genes","volume":"96","author":"Foretz","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B114","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J Anim Physiol Anim Nutr"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04059.x","article-title":"Ethnic differences in the prevalence of cryptogenic cirrhosis","volume":"99","author":"Browning","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","author":"Younossi","year":"2023","journal-title":"Hepatology."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105193200","article-title":"Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage","volume":"276","author":"Baulande","year":"2001","journal-title":"J Biol Chem"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2024.8497","article-title":"Update of the risk assessment of polybrominated diphenyl ethers (PBDEs) in food","author":"Schrenk","year":"2024","journal-title":"EFSA J"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06659","article-title":"Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin","volume":"191","author":"Faraj","year":"2006","journal-title":"J Endocrinol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"NASH CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology."},{"key":"B126","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds","volume":"108","author":"Struben","year":"2000","journal-title":"Am J Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1401120","article-title":"Addressing chemically-induced obesogenic metabolic disruption: selection of chemicals for in vitro human PPAR\u03b1, PPAR\u03b3 transactivation, and adipogenesis test methods","volume":"15","author":"Ozcagli","year":"2024","journal-title":"Front Endocrinol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2023.1212509","article-title":"Development of new approach methods for the identification and characterization of endocrine metabolic disruptors-a PARC project","author":"Braeuning","year":"2023","journal-title":"Front Toxicol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1472563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:46:09Z","timestamp":1743767169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1472563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":129,"alternative-id":["10.3389\/fendo.2025.1472563"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1472563","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1472563"}}